Viewing Study NCT00992758


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-01-03 @ 10:20 PM
Study NCT ID: NCT00992758
Status: COMPLETED
Last Update Posted: 2017-07-25
First Post: 2009-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module